The best treatment option for this problem is intra-articular administration of the human growth hormone. HGH is administered into the joint every 1 or 2 weeks. This allows the cells of the bone to change into cartilage cells. This process is defined as “Morphoangiogenesis”. This process was further studied by an orthopedic surgeon, Allan Dunn at Florida. He suggested that the growth hormone treatment must be performed when no other treatment is going on, as it could damage the growth hormone integrity and in turn the functionality.

0
0
image
http://www.coremedicalgrp.com/wp-content/themes/imperio/
http://www.coremedicalgrp.com/
#3691ad
style2
paged
Loading posts...
/home/coremedi/public_html/
#
off
none
loading
#
Sort Gallery
on
off
off
off